Body Contouring Marketing

Body Contouring Marketing Segmented the Way Patients Actually Search.

Tummy tuck, mommy makeover, and non-surgical each attract a different patient. Treat them that way.

Body contouring is not one procedure. It is four or five distinct patient journeys that share a general category. We build the campaign structure that matches how each of those patients actually searches, so every dollar reaches the right patient at the right moment.

Get My Free AI Marketing Audit

The Problem

Why body contouring practices waste budget on the wrong patients.

×Tummy tuck and mommy makeover in one campaign confuses patients and dilutes ad copy relevance
×Non-surgical contouring and surgical procedures share ad budget that should be entirely separate
×Post-weight-loss body contouring patients have different motivations and are not being targeted separately
×Mommy makeover ads run without the before-and-after gallery and peer testimonials that convert this patient
×GLP-1 and weight loss drug patients creating a new post-weight-loss body contouring segment that is being missed

Risk to your practice

Try us free for 30 days. You cover ad spend only. We waive our management fee entirely. No results, walk away, no questions asked.

Get My Free AI Marketing Audit

Market Data

Body contouring marketing by the numbers.

$15K-$30K

Average mommy makeover procedure value, among the highest in cosmetic surgery

GLP-1 wave

New post-weight-loss body contouring patient segment growing rapidly

30-50%

Consultation-to-booking rate for well-segmented body contouring leads

5 segments

Tummy tuck, mommy makeover, post-weight-loss, non-surgical, revision each need separate campaigns

The Strategy

How we segment body contouring into campaigns that actually convert.

Body contouring is one of the most search-rich categories in cosmetic surgery, and also one of the most frequently mismanaged. The problem is that "body contouring" is not a patient search term. Patients search for the specific procedure they want or the specific problem they have: "tummy tuck surgeon near me," "mommy makeover cost," "CoolSculpting vs tummy tuck," "skin removal after weight loss," or "Emsculpt for abs." Each one is a different patient in a different stage with different motivations.

The GLP-1 wave is creating a significant new patient segment that most practices are not specifically targeting. Patients who have lost 30, 60, or 100 pounds on semaglutide or tirzepatide and are left with loose skin on the abdomen, arms, and thighs are actively researching body contouring surgery, often for the first time. They respond to messaging that acknowledges their weight loss journey and positions surgical contouring as the final step in their transformation. This segment is growing rapidly and the keyword competition is lower than traditional tummy tuck searches because most agencies have not caught up to it yet.

For the mommy makeover specifically, Meta and Instagram are essential alongside Google because this demographic actively researches on social platforms and is influenced by peer results. The campaign structure we build runs Google for decision-stage capture and Meta for relationship building with patients who are in the 3 to 6 month research window before they are ready to consult. The Meta creative that works in this segment is realistic, relatable, and honest about recovery, not aspirational lifestyle imagery.

Segments We Build Campaigns For

Each body contouring patient gets their own strategy.

Tummy Tuck

Post-pregnancy or post-weight-loss patients with skin laxity and muscle separation, seeking permanent abdominal restoration

Mommy Makeover

Combined breast and body procedure patients, typically 30 to 50, done with childbearing and ready for a comprehensive physical transformation

Post-Weight-Loss Body Contouring

GLP-1 and bariatric patients with excess skin, seeking surgical body contouring as the final step after significant weight loss

Non-Surgical Contouring

CoolSculpting, Emsculpt, and device-based fat reduction patients who want results without surgery or significant downtime

FAQ

Body contouring marketing questions answered.

Should I market tummy tuck and mommy makeover in separate campaigns?+

Yes. The tummy tuck patient is focused on removing excess skin and restoring abdominal contour. The mommy makeover patient wants a comprehensive transformation, typically combining breast, abdomen, and sometimes thighs. They search differently, have different average procedure values, and respond to different messaging. Separate campaigns produce better ad relevance and higher consultation rates than a combined body contouring approach.

How do I market CoolSculpting and tummy tuck to the same patient base without confusing them?+

They should not share the same patient acquisition funnel. CoolSculpting attracts patients who want non-invasive fat reduction with minimal downtime. Tummy tuck attracts patients with significant skin laxity who have accepted a surgical recovery in exchange for more dramatic results. Separate campaigns, separate keywords, and separate landing pages keep the messaging clear.

What is the mommy makeover patient demographic and how do I reach them?+

The core mommy makeover demographic is women between 30 and 50 who have completed their family. Google search captures decision-stage patients. Meta and Instagram work well because this demographic is active on social and responds to relatable content about body confidence and the recovery journey. Realistic results in the relevant demographic and peer testimonials are the primary conversion drivers.

How do I capture post-GLP-1 weight loss patients for body contouring?+

Target keywords around "loose skin after weight loss surgery," "skin removal after semaglutide," and "body contouring after ozempic." This patient segment is growing rapidly as GLP-1 adoption expands, and keyword competition is lower than traditional tummy tuck searches because most agencies have not built campaigns specifically around this intent yet. We build these as a separate campaign segment so budget is targeted precisely at this high-converting new patient population.